Lipid Management After First Diagnosis of Coronary Artery Disease: Contemporary Results From an Observational Cohort Study

Author:

Waldeyer Christoph,Seiffert Moritz,Staebe Nils,Braetz Julian,Kohsiack Rebecca,Ojeda Francisco,Schofer Niklas,Karakas Mahir,Zeller Tanja,Sinning Christoph,Schrage Benedikt,Westermann Dirk,Sydow Karsten,Blankenberg Stefan,Brunner Fabian J.,Schnabel Renate B.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference23 articles.

1. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials;Cholesterol Treatment Trialists;Lancet,2010

2. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Lancet,1994

3. EUROASPIRE IV: a European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries;Kotseva;Eur J Prev Cardiol,2016

4. Contemporary data from the DYSIS II ACS/CHD study;Ferrieres;Arch Cardiovasc Dis,2017

5. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology;Task Force;Eur Heart J,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3